Greenwich LifeSciences(GLSI) - 2021 Q2 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NUMBER 001-39555 GREENWICH LIFESCIENCES, INC. (Exact Name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 20-5473709 (I.R.S. Employer Identification No.) 3992 Bluebonnet Dr., Building 14, Stafford, Texas 77477 Form 10-Q (Mark One) ☒ QUART ...